Union Bancaire Privee UBP SA acquired a new position in shares of The Allstate Co. (NYSE:ALL – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 2,000 shares of the insurance provider’s stock, valued at approximately $372,000.
Several other institutional investors also recently modified their holdings of ALL. FSA Wealth Management LLC bought a new position in Allstate during the third quarter valued at approximately $26,000. Northwest Investment Counselors LLC bought a new position in shares of Allstate during the 3rd quarter valued at $28,000. Catalyst Capital Advisors LLC purchased a new position in Allstate in the 3rd quarter worth $29,000. Peoples Bank KS bought a new stake in Allstate in the fourth quarter worth $49,000. Finally, Transamerica Financial Advisors Inc. purchased a new stake in Allstate during the third quarter valued at about $58,000. 76.47% of the stock is currently owned by institutional investors.
Allstate Stock Performance
Shares of Allstate stock opened at $191.21 on Wednesday. The business has a fifty day simple moving average of $194.56 and a two-hundred day simple moving average of $187.88. The firm has a market capitalization of $50.63 billion, a P/E ratio of 12.38, a P/E/G ratio of 1.41 and a beta of 0.52. The company has a current ratio of 0.40, a quick ratio of 0.40 and a debt-to-equity ratio of 0.43. The Allstate Co. has a 12 month low of $153.42 and a 12 month high of $209.88.
Allstate Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Thursday, January 2nd. Shareholders of record on Friday, November 29th were issued a $0.92 dividend. This represents a $3.68 annualized dividend and a yield of 1.92%. The ex-dividend date of this dividend was Friday, November 29th. Allstate’s dividend payout ratio (DPR) is 23.83%.
Analyst Upgrades and Downgrades
ALL has been the subject of several analyst reports. Raymond James increased their target price on Allstate from $205.00 to $220.00 and gave the company a “strong-buy” rating in a report on Friday, October 4th. Evercore ISI raised Allstate from an “in-line” rating to an “outperform” rating in a research note on Wednesday, January 8th. Wells Fargo & Company lifted their target price on shares of Allstate from $186.00 to $187.00 and gave the stock an “equal weight” rating in a research note on Tuesday, January 14th. Morgan Stanley upped their price target on shares of Allstate from $220.00 to $228.00 and gave the company an “overweight” rating in a report on Thursday, November 7th. Finally, UBS Group raised their price target on shares of Allstate from $216.00 to $225.00 and gave the stock a “buy” rating in a report on Monday, November 4th. One analyst has rated the stock with a sell rating, one has issued a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, Allstate currently has an average rating of “Moderate Buy” and an average target price of $218.13.
Check Out Our Latest Report on Allstate
Allstate Company Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Recommended Stories
- Five stocks we like better than Allstate
- Investing in Construction Stocks
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- The Risks of Owning Bonds
- What Does the Future Hold for Eli Lilly?
- Industrial Products Stocks Investing
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.